4.7 Letter

Rapid HIV-RNA decline following addition of raltegravir and tenofovir to ongoing highly active antiretroviral therapy in a woman presenting with high-level HIV viraemia at week 38 of pregnancy

Journal

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 65, Issue 9, Pages 2050-2052

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/jac/dkq264

Keywords

mother to child transmission; drug plasma levels; HAART

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available